Literature DB >> 29559865

Suboxone: Rationale, Science, Misconceptions.

Jennifer R Velander1.   

Abstract

Entities:  

Year:  2018        PMID： 29559865      PMCID： PMC5855417     

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


× No keyword cloud information.
  47 in total

Review 1.  Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

Authors:  John Mendelson; Reese T Jones
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

2.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

3.  Methadone maintenance treatment for 25,000 heroin addicts.

Authors:  V P Dole
Journal:  JAMA       Date:  1971-02-15       Impact factor: 56.272

4.  Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.

Authors:  Jake R Morgan; Bruce R Schackman; Jared A Leff; Benjamin P Linas; Alexander Y Walley
Journal:  J Subst Abuse Treat       Date:  2017-07-03

5.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

Review 6.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  R P Mattick; J Kimber; C Breen; M Davoli
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 7.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 8.  Opioid agonist treatment for pharmaceutical opioid dependent people.

Authors:  Suzanne Nielsen; Briony Larance; Louisa Degenhardt; Linda Gowing; Chyanne Kehler; Nicholas Lintzeris
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

9.  Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population.

Authors:  Naana Afua Jumah; Craig Edwards; Jazmyn Balfour-Boehm; Kassandra Loewen; Joseph Dooley; Lianne Gerber Finn; Len Kelly
Journal:  BMJ Open       Date:  2016-10-31       Impact factor: 2.692

Review 10.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26
View more
  8 in total

1.  Offering Emergency Buprenorphine Without a Prescription.

Authors:  Payel Jhoom Roy; Michael D Stein
Journal:  JAMA       Date:  2019-07-08       Impact factor: 56.272

2.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

3.  Sexual Adverse Effects and Erectile Dysfunction During Buprenorphine/Naloxone Combination Treatment for Opioid Use Disorders.

Authors:  Engin Emrem Bestepe; Nazlı Tunali; Gökçe Elif Sarıdoğan
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-12       Impact factor: 2.570

4.  Decriminalization of Diverted Buprenorphine in Burlington, Vermont and Philadelphia: An Intervention to Reduce Opioid Overdose Deaths.

Authors:  Brandon Del Pozo; Lawrence S Krasner; Sarah F George
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.604

5.  Examining Factors Associated with Non-Fatal Overdose among People Who Inject Drugs in Rural Appalachia.

Authors:  Janet K Otachi; Nikita Vundi; Hilary L Surratt
Journal:  Subst Use Misuse       Date:  2020-06-19       Impact factor: 2.362

6.  Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series.

Authors:  Yvette N Martin; Atousa Deljou; Toby N Weingarten; Darrell R Schroeder; Juraj Sprung
Journal:  BMC Anesthesiol       Date:  2019-05-08       Impact factor: 2.217

7.  Untangling the Complexities of Substance Use Initiation and Recovery: Client Reflections on Opioid Use Prevention and Recovery From a Social-Ecological Perspective.

Authors:  Geoffrey Maina; Kerry Marshall; Jordan Sherstobitof
Journal:  Subst Abuse       Date:  2021-10-13

8.  Use of urinary naloxone levels in a single provider practice: a case study.

Authors:  Jill S Warrington; Kaitlyn Booth; Gregory S Warrington; Samuel Francis-Fath
Journal:  Addict Sci Clin Pract       Date:  2020-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.